Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 12, 2011
Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response, and histopathological findingsDaniel E McLain, Bridget S Lewis, Jennifer L Chapman, et al.Vaccine|March 31, 2007
Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxinsRobert P Webb, Theresa J Smith, Patrick M Wright, et al.Human Vaccines & Immunotherapeutics|January 27, 2016
Recent advances in the development of vaccines against ricinRobert N Brey, Nicholas J Mantis, Seth H Pincus, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Roads from vaccines to therapiesLeonard A Smith, Melody J Jensen, Vicki A Montgomery, et al.Applied and Environmental Microbiology|December 21, 2010
Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxinsSuzanne R Kalb, Jakub Baudys, Christina Egan, et al.Toxins|September 5, 2017
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of BotulismRobert P Webb, Theresa J Smith, Leonard A Smith, et al.Protein Expression and Purification|December 19, 2003
Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastorisScott K Johnson, Wenhui Zhang, Leonard A Smith, et al.Vaccine|April 6, 2007
Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicityJohn H Carra, Robert W Wannemacher, Ralph F Tammariello, et al.Toxicon : Official Journal of the International Society on Toxinology|February 25, 2015
Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitorsVicki A Montgomery, S Ashraf Ahmed, Mark A Olson, et al.Plos One|March 22, 2017
A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypesYongfeng Fan, Consuelo Garcia-Rodriguez, Jianlong Lou, et al.Pageof 10